CuraGen and DuPont Announce Collaboration to Explore the Power of Genomics to Enhance Crop Protection Product Discovery and Development.NEW HAVEN New Haven, city (1990 pop. 130,474), New Haven co., S Conn., a port of entry where the Quinnipiac and other small rivers enter Long Island Sound; inc. 1784. Firearms and ammunition, clocks and watches, tools, rubber and paper products, and textiles are among the many , Conn. and WILMINGTON, Del.--(BUSINESS WIRE)--July 20, 1998--CuraGen Corporation (Nasdaq:CRGN) and DuPont Agricultural Enterprise, a unit of E.I. du Pont de Nemours Du Pont de Ne·mours , Pierre Samuel 1739-1817. French-born economist and politician who took part in negotiations after the American Revolution (1783) and in the acquisition of the Louisiana Territory (1803). and Company (NYSE NYSE See: New York Stock Exchange :DD), announced today the signing of a collaborative research agreement to explore the application of genomics to enhance the discovery and development of crop protection products. "The agreement strongly supports DuPont's commitment to Life Sciences. We believe that genomics will accelerate DuPont's effort to discover and develop novel, environmentally safe crop protection products with optimal specificity for target organisms," said Elmo Beyer, Vice President for Global Research and Development, DuPont Agricultural Enterprise. "Being able to comprehensively survey and quantify changes in gene expression after application of a crop protection product dramatically enhances our ability to understand the relationship between the product and its mode-of-action." Under the agreement, CuraGen will use its suite of proprietary processes, technologies, and bioinformatics Using computers in biological research to analyze or predict the composition of molecules (nucleic acids, proteins, etc.) and model biologic systems. Bioinformatics is most prominent in the Human Genome Project, which has recorded the three billion chemical base pairs that make up the to elucidate e·lu·ci·date v. e·lu·ci·dat·ed, e·lu·ci·dat·ing, e·lu·ci·dates v.tr. To make clear or plain, especially by explanation; clarify. v.intr. To give an explanation that serves to clarify. and characterize the genetic components and metabolic pathways underlying the action of a highly promising new DuPont crop protection product. The financial terms were not disclosed. With the agreement, CuraGen continues to expand its portfolio of agricultural applications. To date, CuraGen has active programs with Pioneer Hi-Bred Pioneer Hi-Bred is one of the largest U.S. companies which produces hybrid seeds for agriculture. History In 1926, farm journal editor and future U.S. Vice President Henry A. Wallace, along with a group of Des Moines, Iowa businessmen, started the "Hi-Bred Corn Company". International, Inc., the leader in the development of agronomic a·gron·o·my n. Application of the various soil and plant sciences to soil management and crop production; scientific agriculture. ag seed products, and Biogen, Inc., and Genentech, Inc., leaders in the development of pharmaceuticals. "We have successfully applied our suite of proprietary processes, technologies, and bioinformatics to pharmaceutical discovery and development and plant improvement applications. With the results we have, it's clear that our technology will be equally powerful to enhance the discovery and development of crop protection products," said Greg Went, Executive Vice President and Co-Founder. Dr. Went added, "We are especially pleased to be working with DuPont. Not only is DuPont an industry leader, but, with our mutual association with Pioneer Hi-Bred, the potential exists for world-class synergy The enhanced result of two or more people, groups or organizations working together. In other words, one and one equals three! It comes from the Greek "synergia," which means joint work and cooperative action. . Each party brings resources, complementary knowledge, and experience in chemistry, genetics, and genomics technology that are unsurpassed in the industry." The DuPont Agricultural Enterprise is a DuPont business that includes crop protection, feed, seed, food ingredient, and food safety businesses, with sales of $2.6 billion in 1997. Founded in 1802, DuPont is a global research and technology-based life sciences, materials, and energy company. CuraGen Corporation is revolutionizing the discovery and development of life science products through the systematic application of genomics. CuraGen's fully-integrated genomics technologies, processes, and information systems are designed to rapidly generate comprehensive information about gene expression, biological pathways, and potential products that affect these pathways, each on a scale not previously undertaken. The Company completed an Initial Public Offering on March 18, 1998. Except for the historical information contained herein, the matters set forth in this press release are forward-looking statements forward-looking statement A projected financial statement based on management expectations. A forward-looking statement involves risks with regard to the accuracy of assumptions underlying the projections. within the meaning of the "safe harbor Safe Harbor 1. A legal provision to reduce or eliminate liability as long as good faith is demonstrated. 2. A form of shark repellent implemented by a target company acquiring a business that is so poorly regulated that the target itself is less attractive. " provisions of the Private Securities Litigation Reform Act The Private Securities Litigation Reform Act of 1995 (PSLRA) implemented several significant substantive changes affecting certain cases brought under the federal securities laws, including changes related to pleading, discovery, liability, class representation and awards fees and of 1995. These forward-looking statements are subject to risks and uncertainties that may cause actual results to differ materially. For a discussion of factors that may cause results to differ, see CuraGen's SEC filing and prospectus dated March 18, 1998. These forward-looking statements speak only as of the date hereof. CuraGen disclaims any intent or obligation to update these forward-looking statements.
CONTACT: CuraGen Corporation
Gregory Went, Ph.D.
203/401-3330, ext. 231
or
DuPont
Gabrielle King
302/992-6285
|
|
||||||||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion